TrialAdvances in therapy2015

Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.

Laura Ordoñez-Boschetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.